MondayMar 07, 2022 11:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session at Virtual Investor 2022 Top Picks Conference

The company also participated in the H.C. Wainwright BioConnect Conference earlier in January CNS Pharmaceuticals recently received approval from swissethics for a pivotal Berubicin and GBM clinical trial The five-year survival rate for GBM is only 6.8%, with the average patient population surviving 12 to 18 months after diagnosis CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. During the event, CEO John Climaco provided a corporate presentation and then participated in a…

Continue Reading

MondayMar 07, 2022 11:15 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Is ‘One to Watch’

EverGen forecasts EBITDA growth from about C$3 million in 2021 to more than C$12 million in the next 12 months from expansion of core operating assets EverGen stock began trading in the U.S. on the OTCQB Venture Market under ticker symbol ‘EVGIF’ on February 15, 2022 EverGen has low-risk long term contracted or reoccurring revenue (similar to Large Cap Independent Power Producers), with two revenue sources via RNG sales and organic waste tip-fee contracts providing a high margin business with EBITDA margins of 50-60% In its most recent reporting, the company reported gross profit of C$1.58 million on revenue of…

Continue Reading

MondayMar 07, 2022 11:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics

Psychedelic drugs are on cusp of entering mainstream treatment for mental illness Cybin, Chopra Foundation to collaborate on efforts aimed to support education, awareness about psychedelic therapy mental health research Cybin “one of the only companies that may truly address the needs of patients and providers,” says Dr. Deepak Chopra A significant increase in research and growing public support are key indicators of the future of psychedelics, which are “on the cusp of entering mainstream psychiatry,” according to a recent “New York Times” article (https://ibn.fm/GshwS). Another strong indicator of the future of psychedelics is the exciting partnership just announced by…

Continue Reading

MondayMar 07, 2022 11:00 am

Cepton Inc.’s (NASDAQ: CPTN) Management Rings Nasdaq Opening Bell After Commencing Formal Trade on the Exchange

Cepton, Inc formally listed on the Nasdaq Capital Market on February 11, 2022, following the merger between Cepton Technologies Inc., and SPAC, Growth Capital Acquisition Corp (GCAC) Cepton’s CEO, Dr. Jun Pei rang the Nasdaq opening bell on Thursday, February 17, alongside CTO Dr. Mark McCord and members of both, Cepton Technologies and Growth Capital Acquisition Corp GCAC and Cepton arrived at a formal combination agreement on August 5, 2021, with the transaction valuing Cepton at an enterprise value of $1.5 billion Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMR(R) lidar solutions, held the opening bell…

Continue Reading

MondayMar 07, 2022 10:54 am

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Present in Upcoming Fintech Conference

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be participating in the 35th annual Roth Conference. GBOX chair Ben Errez and chief financial officer Ben Chung will attend the event, make a presentation, and be available for one-on-one and small group meetings with investors. The event is scheduled for March 13–15, 2022, and will be held in person in Dana Point, California. The Greenbox executives will present at on March 15 at noon PT. The elite event includes one-on-one and small-group meetings between carefully selected companies and institutional investors. In addition, the event will include fireside chats,…

Continue Reading

MondayMar 07, 2022 10:00 am

QualityStocksNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) FIVE EV Crossover Featured in Clean Fleet Report Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a recent article published by the Clean Fleet Report. The piece titled “A Quick Look at What Is on the Electric Horizon,” provides a glimpse of the future of EVs. “With a corporate motto of ‘Imagine What’s Possible,’ the Southern California-based Mullen Technologies planted its flag in 2014 with the goal of helping to lower the impact of fossil fuels on the environment. Their first foray into being part of the solution for better air will be the Mullen FIVE with an estimated 325-mile all-electric driving range.…

Continue Reading

FridayMar 04, 2022 2:08 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) On Path Toward Improved Margins Through Vertical Integration

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a cannabis and CBD product brand builder with a presence in California, Arizona, Oklahoma, Illinois, Michigan, and Florida, most recently celebrated the news that Michigan had granted it adult recreational use prequalification status for manufacture, followed by full licensing to make both medical and adult-use cannabis products in the state. “The company’s lease assignment for a 15,000-square-foot manufacturing and processing facility in the city of Warren led to the launch of operations there [in January], with ‘all necessary equipment already installed and inspections completed’ for medical and adult-use products,” a recent…

Continue Reading

FridayMar 04, 2022 1:48 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Expecting Its ‘Largest Quarter Ever in Q1 of 2022’

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently issued its guidance for the upcoming financial year. “SRAX guided that the company was forecasting revenues of $11.5 million for the first quarter of 2022, with full-year revenues of $46-48 million. The numbers follow a strong series of recent results, with SRAX reporting $8.3 million in third-quarter revenues, with street analysts forecasting top-line sales to further increase to $10.05 million in the fourth quarter. Fourth-quarter results for 2021 are expected to be published on Monday, April 4,…

Continue Reading

FridayMar 04, 2022 1:12 pm

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) Green Ammonia System Touted as Solution to Hydrogen Transportation Conundrum

FuelPositive’s (TSX.V: NHHH) (OTCQB: NHHHF) vision for its modular, scalable and portable green ammonia production technology was reinforced by observations contained in a Recharge special report. Designed to produce green ammonia from water, air and renewable electricity, the system is touted as a solution to the hydrogen transportation conundrum. According to FuelPositive, green ammonia, which is hydrogen dense and is much easier to store and transport using existing infrastructure, is the perfect vector for hydrogen. “As a liquid, hydrogen needs cryogenic temperature of -253°C, while as a gas, it has to be kept at extremely high pressure. At the same…

Continue Reading

FridayMar 04, 2022 12:09 pm

QualityStocksNewsBreaks – Why AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Is ‘One to Watch’

AREV Life Sciences (CSE: AREV) (OTC: AREVF) is dedicated to delivering therapeutic interventions to public health through discovery, innovation and successful industry collaborations. Its leadership team is focused on driving discovery programs for clinical complexities demonstrated by malnutrition, the inflammatory response system and viral infectious diseases. “AREV’s business model leverages the core competency of producing proprietary compounds through its innovative extraction methodologies, scientific advisory board (‘SAB’), experienced staff, and executive leadership to drive its product pipeline,” reads a recent article discussing the company. “AREV’s strategy is to generate revenue from selling its branded products via its online technology platform, Medicine…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered